BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4717706)

  • 1. Delayed cutaneous hypersensitivity reactions to extracts of malignant and normal breast cells.
    Alford C; Hollinshead AC; Heberman RB
    Ann Surg; 1973 Jul; 178(1):20-4. PubMed ID: 4717706
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolation and identification of soluble skin-reactive membrane antigens of malignant and normal human breast cells.
    Hollinshead AC; Jaffurs WT; Alpert LK; Harris JE; Herberman RB
    Cancer Res; 1974 Nov; 34(11):2961-8. PubMed ID: 4138143
    [No Abstract]   [Full Text] [Related]  

  • 3. Delayed cutaneous hypersensitivity reactions to extracts of human tumors.
    Herberman RB; Hollinshead AC; Alford TC; McCoy JL; Halterman RH; Leventhal BG
    Natl Cancer Inst Monogr; 1973 Jun; 37():189-95. PubMed ID: 4123453
    [No Abstract]   [Full Text] [Related]  

  • 4. Delayed cutaneous hypersensitivity reactions to extracts of breast cancer and melanoma tissue in cancer patients.
    Fossati G; Canevari S; Pierotti MA; Vezzoni P; Porta GD; Vaglini M
    J Natl Cancer Inst; 1979 Jun; 62(6):1381-5. PubMed ID: 286110
    [No Abstract]   [Full Text] [Related]  

  • 5. The presence of delayed hypersensitivity reactions in patients toward cellular extracts of their malignant tumors. 3. The frequency, duration, and cross reactivity of this phenomenon in patients with breast cancer, and its correlation with survival.
    Stewart TH; Orizaga M
    Cancer; 1971 Dec; 28(6):1472-8. PubMed ID: 5127795
    [No Abstract]   [Full Text] [Related]  

  • 6. Delayed hypersensitivity skin reactions to antigens on human tumors.
    Herberman RB
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1469-73. PubMed ID: 4609389
    [No Abstract]   [Full Text] [Related]  

  • 7. Delayed-hypersensitivity reactions to soluble membrane antigens of human malignant lung cells.
    Hollinshead AC; Stewart TH; Herberman RB
    J Natl Cancer Inst; 1974 Feb; 52(2):327-38. PubMed ID: 4131424
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo and in vitro assays of cellular immunity to human tumor antigens.
    Herberman RB
    Fed Proc; 1973 Feb; 32(2):160-4. PubMed ID: 4120197
    [No Abstract]   [Full Text] [Related]  

  • 9. A possible role for cross-reacting antigens in conditioning immunological surveillance mechanisms in cancer and transplantation. II. Prospective studies of altered cellular immune reactivity in cancer patients.
    Rapaport FT; Lawrence HS
    Transplant Proc; 1975 Jun; 7(2):281-5. PubMed ID: 1129846
    [No Abstract]   [Full Text] [Related]  

  • 10. Human breast cancer. A model for cancer immunology.
    Black MM
    Isr J Med Sci; 1973 Mar; 9(3):284-99. PubMed ID: 4575653
    [No Abstract]   [Full Text] [Related]  

  • 11. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.
    Bluming AZ; Vogel CL; Ziegler JL; Kiryabwire JW
    J Natl Cancer Inst; 1972 Jan; 48(1):17-24. PubMed ID: 4652371
    [No Abstract]   [Full Text] [Related]  

  • 12. Cutaneous delayed hypersensitivity reactions to soluble melanoma antigen in patients with ocular malignant melanoma.
    Char DH; Hollinshead A; Cogan DG; Ballintine EJ; Hogan MJ; Herberman RB
    N Engl J Med; 1974 Aug; 291(6):274-7. PubMed ID: 4407111
    [No Abstract]   [Full Text] [Related]  

  • 13. Specificity of delayed cutaneous hypersensitivity reactions to extracts of human tumor cells.
    Weese JL; Herberman RB; Hollinshead AC; Cannon GB; Keels M; Kibrite A; Morales A; Char DH; Oldham RK
    J Natl Cancer Inst; 1978 Feb; 60(2):255-63. PubMed ID: 74413
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunity and cancer.
    Barg S; Levin M; Rezzonico R
    Int Adv Surg Oncol; 1981; 4():337-47. PubMed ID: 7251176
    [No Abstract]   [Full Text] [Related]  

  • 15. The presence of delayed hypersensitivity reactions in patients toward cellular extracts of their malignant tumors. 1. The role of tissue antigen, nonspecific reactions of nuclear material, and bacterial antigen as a cause for this phenomenon.
    Stewart TH
    Cancer; 1969 Jun; 23(6):1368-79. PubMed ID: 4181583
    [No Abstract]   [Full Text] [Related]  

  • 16. Delayed cutaneous hypersensitivity reactions to membrane extracts of human tumour cells.
    Oren ME; Herberman RB
    Clin Exp Immunol; 1971 Jul; 9(1):45-56. PubMed ID: 5559094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed hypersensitivity reactions in patients with breast cancer.
    Boeva M; Donchev T; Markova R; Christov I
    Neoplasma; 1978; 25(6):733-6. PubMed ID: 752118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed cutaneous hypersensitivity reactions to membrane extracts of carcinomatous cells of the cervix uteri.
    Wells SA; Melewicz FC; Christiansen C; Ketcham AS
    Surg Gynecol Obstet; 1973 May; 136(5):717-20. PubMed ID: 4701902
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies of tumor-specific and herpesvirus nonvirion antigens.
    Hollinshead A; Tarro G; Foster WA; Seigel LJ; Jaffurs W
    Cancer Res; 1974 May; 34(5):1122-5. PubMed ID: 4842911
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship of skin reactive intestinal cancer antigen to the carcinoembryonic antigen of Gold and other antigens.
    Herberman RB; Hollinshead AC; von Kleist S
    Ann Immunol (Paris); 1973 Nov; 124(4):597-8. PubMed ID: 4134476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.